Symposium 36 (open)
Atomoxetine, Placebo, and Parent Training in Autism

Saturday, October 25, 2014: 8:30 AM-11:30 AM
Chair:
Benjamin L. Handen, PhD
Discussant:
Bryan H. King, MD
 
36.1
Children with Hyperactivity and Autism – Research Treatment Study
Tristram Smith, PhD Strong Center for Developmental Disabilities, Rochester, NY
Michael Aman, PhD The Ohio State University, Columbus, OH
Laura B. Silverman, PhD University of Rochester Medical Center, Rocester, NY
 
36.2
Atomoxetine, Placebo, and Parent Training in Autism: Primary Outcome Measures
Benjamin L. Handen, PhD Western Psychiatric Institute and Clinic, Pittsburgh, PA
L. Eugene Arnold, MD Ohio State University, Columbus, OH
Jessica A. Hellings, MD The Ohio State University Nisonger Center, Columbus, OH
Xueliang Pan, PhD Ohio State University, Columbus, OH
 
36.3
Atomoxetine, Placebo, and Parent Training in Autism: Adverse Effects
Patricia Corbett-Dick, MS, RN Kirch Developmental Services Center and University of Rochester Medical Center, Rochester, NY
Rameshwari Tumuluru, MD Western Psychiatric Institute and Clinic, Pittsburgh, PA
Susan L. Hyman, MD Strong Center for Developmental Disabilities, Rochester, NY
 
36.4
Consumer Satisfaction with Combination Therapy for Treating ADHD and Noncompliance in Children With Autism Spectrum Disorder
Jill A. Hollway, PhD The Ohio State University, Columbus, OH
Kristin Page, BA Ohio State University, Columbus, OH
Robert Rice Jr., PhD The Ohio State University, Columbus, OH
Luc Lecavalier, PhD Ohio State University, Columbus, OH

See more of: Symposium
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.